08/19/2026
Weβve just published what we believe is the first clinical trial of a treatment for primary age-related sarcopenia in cats. ππΌ
In a randomized, double-blind, placebo-controlled trial, our multi-target therapeutic showed significant positive effects on key measures of age-related muscle loss vs. placebo. πͺ
A step toward treating one of the most consequential and under-studied manifestations of aging in cats.
Preprint linked in the comments.